Tepotinib is a type of MET inhibitor used for treating Non-Small Cell Lung Cancer that has a specific kind of mutation in the MET gene. It works by stopping the MET signaling in its tracks. The drug comes as a tablet that’s coated and is available in a 225 mg dose.
Doctors usually recommend taking 450 mg of the stuff once a day, and it’s best to have it with something to eat. It comes in bottles, each with 30 tablets. This treatment is really important for dealing with NSCLC when there’s a MET mutation.
